FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

FDA Overhauls REMS Web Resources

Feb. 1, 2018
A A

The FDA launched a new set of webpages on Risk Evaluation and Mitigation Strategy programs, organizing information according to the role a person might have in a REMS program in a short question-answer format.

The agency overhauled the site in response to users who reported difficulty finding information about drug-specific REMS and general REMS topics on the web.

“Our goal is to enable easier compliance with these programs so that patient access to drugs with REMS can be maintained, while still preserving their safe use,” the FDA said.

View today's stories